Atlas Trials

Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET

Clinical trial NCT04385992 · COMPLETED

Trial details

NCT number
NCT04385992
Sponsor
IRCCS San Raffaele
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2020-03-09
Primary completion
2023-01-25
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.